In human and experimental models, CCL2 contributes to a variety of renal diseases, including progressive renal damage such as chronic rejection of renal transplantation, lupus nephritis, lgA nephropathy, and diabetic nephropathy [25–28]. Here, CCL2 is linked to diabetic kidney disease.